TransMedics to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
TransMedics Group, Inc. (Nasdaq: TMDX), a medical technology company focused on transforming organ transplant therapy, has announced its participation in the Morgan Stanley 22nd Annual Global Healthcare Conference. The event will take place on Wednesday, September 4, 2024, at 1:05 p.m. Eastern Time at the Marriott Marquis New York.
Members of TransMedics' management team will engage in a fireside chat during the conference. Investors and interested parties can access a live and archived webcast of the discussion through the 'Investors' section of the TransMedics website. Additionally, the company's standard investor presentation is available for viewing on the same platform.
TransMedics Group, Inc. (Nasdaq: TMDX), un'azienda tecnologica medica focalizzata sulla trasformazione della terapia di trapianto d'organo, ha annunciato la sua partecipazione alla 22° Conferenza Globale Annuale sulla Salute di Morgan Stanley. L'evento si terrà mercoledì 4 settembre 2024, alle 13:05 ora orientale, presso il Marriott Marquis di New York.
I membri del team di gestione di TransMedics parteciperanno a una conversazione informale durante la conferenza. Gli investitori e le parti interessate possono accedere a un webcast in diretta e registrato della discussione attraverso la sezione 'Investitori' del sito web di TransMedics. Inoltre, la presentazione standard per gli investitori dell'azienda è disponibile per la visualizzazione sulla stessa piattaforma.
TransMedics Group, Inc. (Nasdaq: TMDX), una empresa de tecnología médica enfocada en transformar la terapia de trasplante de órganos, ha anunciado su participación en la 22ª Conferencia Anual Global de Salud de Morgan Stanley. El evento se llevará a cabo el miércoles 4 de septiembre de 2024, a la 1:05 p.m. hora del este, en el Marriott Marquis de Nueva York.
Los miembros del equipo de gestión de TransMedics participarán en una charla junto a la chimenea durante la conferencia. Los inversores y partes interesadas pueden acceder a un webcast en vivo y grabado de la discusión a través de la sección 'Inversores' en el sitio web de TransMedics. Además, la presentación estándar para inversores de la empresa está disponible para su visualización en la misma plataforma.
TransMedics Group, Inc. (Nasdaq: TMDX), 장기 이식 치료의 혁신에 중점을 둔 의료 기술 회사는 모건 스탠리 제22회 연례 글로벌 헬스케어 컨퍼런스에 참가한다고 발표했습니다. 이 행사는 2024년 9월 4일 수요일, 동부 표준시 기준 오후 1시 5분에 뉴욕의 Marriott Marquis에서 열립니다.
TransMedics의 경영진이 컨퍼런스에서 대담에 참여할 예정입니다. 투자자 및 관심 있는 분들은 TransMedics 웹사이트의 '투자자' 섹션을 통해 대담의 실시간 및 녹화된 웹캐스트를 접근할 수 있습니다. 또한 회사의 표준 투자자 프레젠테이션은 동일한 플랫폼에서 보기 가능합니다.
TransMedics Group, Inc. (Nasdaq: TMDX), une entreprise de technologie médicale axée sur la transformation de la thérapie de transplantation d'organes, a annoncé sa participation à la 22ème conférence mondiale annuelle sur la santé de Morgan Stanley. L'événement se tiendra le mercredi 4 septembre 2024, à 13h05 heure de l'Est, au Marriott Marquis de New York.
Les membres de l'équipe de direction de TransMedics participeront à un chat informel lors de la conférence. Les investisseurs et les parties intéressées peuvent accéder à un webcast en direct et archivé de la discussion via la section 'Investisseurs' du site web de TransMedics. De plus, la présentation standard de l'entreprise pour les investisseurs est disponible en consultation sur la même plateforme.
TransMedics Group, Inc. (Nasdaq: TMDX), ein Medizintechnikunternehmen, das sich auf die Transformation der Organtransplantationstherapie konzentriert, hat seine Teilnahme an der 22. jährlichen globalen Gesundheitskonferenz von Morgan Stanley bekannt gegeben. Die Veranstaltung findet am Mittwoch, den 4. September 2024, um 13:05 Uhr Eastern Time im Marriott Marquis New York statt.
Mitglieder des Managementteams von TransMedics werden während der Konferenz an einem Fireside-Chat teilnehmen. Investoren und Interessierte können über den Bereich 'Investoren' der TransMedics-Website auf einen live und archivierten Webcast der Diskussion zugreifen. Darüber hinaus ist die Standardpräsentation für Investoren des Unternehmens auf derselben Plattform verfügbar.
- None.
- None.
Event: Morgan Stanley 22nd Annual Global Healthcare Conference
Date: Wednesday, September 4, 2024
Time: 1:05 p.m. ET
A live and archived webcast of the fireside chat will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com. The Company's standard investor presentation is also available through this link.
About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in
Investor Contact:
Brian Johnston
332-895-3222
Investors@transmedics.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/transmedics-to-participate-in-the-morgan-stanley-22nd-annual-global-healthcare-conference-302227550.html
SOURCE TransMedics Group, Inc.
FAQ
When and where is TransMedics (TMDX) participating in the Morgan Stanley Healthcare Conference?
How can investors access TransMedics' (TMDX) fireside chat at the Morgan Stanley conference?
What is the focus of TransMedics Group (TMDX) as a medical technology company?
Is TransMedics' (TMDX) investor presentation available for viewing?
